Company news
Impedimed Limited (ASX:IPD) news
Impedimed Limited news releases on 6ix. Latest, Nov 6, 2017: 2018 Reimbursement Amounts Published by CMS
Press releases — page 4
2018 Reimbursement Amounts Published by CMS
November 5, 2017
Multi-year Exclusive Distribution Agreement Signed
October 30, 2017
Appendix 4C - Quarter ended 30 September 2017
October 24, 2017
Shipments of SOZO with L-Dex Commence in the US
October 22, 2017
New Study Reports Superior Clinical Outcomes Utilising L-Dex
August 24, 2017
Appendix 4E - year ended 30 June 2017
August 22, 2017
Heart Failure 510(k) Application for SOZO Submitted to FDA
August 21, 2017
US FDA 510(k) Clearance Issued for SOZO with L-Dex
August 14, 2017
First patient enrolled in SOZO CHF Trial at Scripps Health
August 8, 2017
Appendix 4C - Quarter ended 30 June 2017
July 23, 2017
IPD Submits FDA 510(k) Application for SOZO for Lymphoedema
July 16, 2017
L-Dex Recommended in Clinical Practice Guidelines
July 4, 2017
SOZO obtains CE Mark for Heart Failure Patient Monitoring
June 20, 2017
Macquarie University Commences Lymphoedema Study Using Sozo
June 14, 2017
L-Dex Study - Significant Reduction in Clinical Lymphoedema
May 17, 2017
March 2017 Quarter Results & Investor Conference Call
April 25, 2017
SOZO Shipped to Vanderbilt to Commence At-Home Study
April 23, 2017
Placement of First SOZO Unit at Scripps Health
March 6, 2017
Appendix 4D and Financial Report 31 December 2016
February 23, 2017
Appendix 4C - Quarter Ended 31 December 2016
January 30, 2017
Appendix 4C - Quarter Ended 30 September 2016
October 25, 2016
Study on Efficacy of L-Dex in Routine Clinical Practice
September 13, 2016
Appendix 4E and Press Release
August 23, 2016
SOZO Launched - First Product for Health and Wellness Market
August 11, 2016
Scripps to use SOZO in Heart Failure Study
August 9, 2016
Appendix 4C - Quarter Ended 30 June 2016
July 28, 2016
IPD and Mayo Clinic Sign Joint Development Agreement
July 27, 2016
Relationship with Redox to Expand EHR Integration Capability
July 20, 2016
Vanderbilt to Begin Testing Next Generation Device
July 17, 2016
Medicare Proposes New Reimbursement Rates, L-Dex Increases
July 12, 2016
Five Year Multi-Location Clinical Trial with Mayo Clinic
May 29, 2016
Appendix 4C - Quarter Ended 31 March 2016
April 19, 2016
Strategic Realignment
March 30, 2016
Appendix 4D and Interim Report Ended 31 December 2015
February 24, 2016
A$75M Private Placement and A$7.5M Share Purchase Plan
February 11, 2016
Appendix 4C - Quarter Ended 31 December 2015
February 10, 2016